These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10679744)

  • 1. Bcl-2: bax and bcl-2: Bcl-x ratios by image cytometric quantitation of immunohistochemical expression in ovarian carcinoma: correlation with prognosis.
    Lohmann CM; League AA; Clark WS; Lawson D; DeRose PB; Cohen C
    Cytometry; 2000 Feb; 42(1):61-6. PubMed ID: 10679744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis.
    Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C
    Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.
    Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM
    Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas.
    Shigemasa K; Katoh O; Shiroyama Y; Mihara S; Mukai K; Nagai N; Ohama K
    Jpn J Cancer Res; 2002 May; 93(5):542-50. PubMed ID: 12036450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAX protein expression and clinical outcome in epithelial ovarian cancer.
    Tai YT; Lee S; Niloff E; Weisman C; Strobel T; Cannistra SA
    J Clin Oncol; 1998 Aug; 16(8):2583-90. PubMed ID: 9704707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
    Xie X; Clausen OP; De Angelis P; Boysen M
    Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy.
    Skirnisdóttir I; Seidal T; Gerdin E; Sorbe B
    Int J Gynecol Cancer; 2002; 12(3):265-76. PubMed ID: 12060448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer.
    Baekelandt M; Holm R; Nesland JM; Tropé CG; Kristensen GB
    J Clin Oncol; 2000 Nov; 18(22):3775-81. PubMed ID: 11078490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer.
    Marx D; Binder C; Meden H; Lenthe T; Ziemek T; Hiddemann T; Kuhn W; Schauer A
    Anticancer Res; 1997; 17(3C):2233-40. PubMed ID: 9216694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen.
    Kupryjańczyk J; Szymańska T; Madry R; Timorek A; Stelmachów J; Karpińska G; Rembiszewska A; Ziółkowska I; Kraszewska E; Debniak J; Emerich J; Ułańska M; Płuzańska A; Jedryka M; Goluda M; Chudecka-Głaz A; Rzepka-Górska I; Klimek M; Urbański K; Breborowicz J; Zieliński J; Markowska J
    Br J Cancer; 2003 Mar; 88(6):848-54. PubMed ID: 12644821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis.
    Cohen C; Lohmann CM; Cotsonis G; Lawson D; Santoianni R
    Mod Pathol; 2003 Jun; 16(6):574-83. PubMed ID: 12808063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53, bcl-2, and bax: their relationship and effect on prognosis in early stage epithelial ovarian carcinoma.
    Skirnisdóttir I; Sorbe B; Seidal T
    Int J Gynecol Cancer; 2001; 11(2):147-58. PubMed ID: 11328414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome.
    Peiró G; Diebold J; Baretton GB; Kimmig R; Löhrs U
    Int J Gynecol Pathol; 2001 Oct; 20(4):359-67. PubMed ID: 11603220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of bcl-2, bax, mcl-1, and bcl-X expression in ovarian surface epithelial tumors.
    Wehrli BM; Krajewski S; Gascoyne RD; Reed JC; Gilks CB
    Int J Gynecol Pathol; 1998 Jul; 17(3):255-60. PubMed ID: 9656122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma and markers of apoptosis (bcl-2, bax, bcl-x): prognostic significance.
    Garcia EJ; Lawson D; Cotsonis G; Cohen C
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):210-7. PubMed ID: 12373145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of bcl-2, bax, and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters.
    Salakou S; Tsamandas AC; Bonikos DS; Papapetropoulos T; Dougenis D
    Eur J Cardiothorac Surg; 2001 Oct; 20(4):712-21. PubMed ID: 11574213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas.
    Ogura E; Senzaki H; Yamamoto D; Yoshida R; Takada H; Hioki K; Tsubura A
    Oncol Rep; 1999; 6(2):365-9. PubMed ID: 10023006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of expression and correlation between P53, BCL-2 and BAX proteins in ovarian neoplasms].
    Bar JK; Sobańska E; Popiela A; Goluda M
    Ginekol Pol; 2002 Feb; 73(2):102-9. PubMed ID: 12001767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x.
    Pollack A; Cowen D; Troncoso P; Zagars GK; von Eschenbach AC; Meistrich ML; McDonnell T
    Cancer; 2003 Apr; 97(7):1630-8. PubMed ID: 12655519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
    Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S
    J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.